{
    "nct_id": "NCT02833857",
    "official_title": "An Open-label, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Etelcalcetide (AMG 416) in Paediatric Subjects Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Maintenance Haemodialysis",
    "inclusion_criteria": "* Subject's parent has provided informed consent and subject has provided assent\n* Children Age 2 to less than 18 years\n* Diagnosed with chronic kidney disease\n* Diagnosed with secondary hyperparathyroidism receiving hemodialysis,\n* Weighing at least 7 kg\n* Laboratory results within specified range.\nHealthy volunteers allowed\nMust have minimum age of 2 Years\nMust have maximum age of 17 Years",
    "exclusion_criteria": "* Currently receiving treatment in another investigation device or drug study\n* Subject has received cinacalcet therapy within 30 days\n* History of prolongation QT interval\n* Subject is taking any medications that are on the QT prolongation medication list\n* Electrocardiograph (ECG) measurements within specified range.",
    "miscellaneous_criteria": ""
}